An Extension Study for Participants Who Have Completed the Treatment Period of a Qualifying Parent Study

Summary

The purpose of this research study is to evaluate the long-term safety, and tolerability of PF-06823859 study drug in adult participants with Dermatomyositis (DM) from a qualifying study.

Timeline

Start

2021-12-20

Primary completion

2023-11-20

Completion

2023-11-20

Drugs

Indications